Cargando…

Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors

Angiogenesis is essential for tumor growth and metastasis. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an angiogenic factor predominantly expressed in steroidogenic organs like the adrenal gland, ovary, testes, and placenta. EG-VEGF has antiapoptotic, mitogenic, and chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Heck, Dorothee, Wortmann, Sebastian, Kraus, Luitgard, Ronchi, Cristina L., Sinnott, Richard O., Fassnacht, Martin, Sbiera, Silviu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630243/
https://www.ncbi.nlm.nih.gov/pubmed/26475302
http://dx.doi.org/10.1007/s12672-015-0236-z
_version_ 1782398667543543808
author Heck, Dorothee
Wortmann, Sebastian
Kraus, Luitgard
Ronchi, Cristina L.
Sinnott, Richard O.
Fassnacht, Martin
Sbiera, Silviu
author_facet Heck, Dorothee
Wortmann, Sebastian
Kraus, Luitgard
Ronchi, Cristina L.
Sinnott, Richard O.
Fassnacht, Martin
Sbiera, Silviu
author_sort Heck, Dorothee
collection PubMed
description Angiogenesis is essential for tumor growth and metastasis. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an angiogenic factor predominantly expressed in steroidogenic organs like the adrenal gland, ovary, testes, and placenta. EG-VEGF has antiapoptotic, mitogenic, and chemoattractive properties mediated via the two G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). We investigated the expression of EG-VEGF and its receptors in a large number of normal adrenal glands (NAG), adrenocortical adenomas (ACA), and carcinomas (ACC) using real-time PCR (NAG, n = 12; ACA, n = 24; and ACC, n = 30) and immunohistochemistry (NAG, n = 9; ACA, n = 23; and ACC, n = 163) and evaluated its impact on patients’ survival. EG-VEGF, PKR1, and PKR2 mRNA and protein are expressed in NAG and the vast majority of ACA and ACC samples. The mean EG-VEGF mRNA expression was significantly lower in ACC (606.5 ± 77.1 copies) compared to NAG (4,043 ± 1,111) and cortisol-producing adenomas (CPA) (4,433 ± 2,378) (p < 0.01 and p < 0.05, respectively). However, cytoplasmic and nuclear EG-VEGF protein expression was either significantly higher or similar in ACC (H score 2.4 ± 0.05, p < 0.05 and 1.7 ± 0.08, n.s., respectively) compared to NAG (1.8 ± 0.14 and 1.7 ± 0.2). Nuclear protein expression of either EG-VEGF or PKR1 or both is predictive for a higher mortality compared to patients without nuclear expression (hazard ratio (HR) = 5.15; 95 % confidence interval (CI) = 1.24–21.36, n = 100, p = 0.02 independent of age, sex, and tumor stage). These findings suggest that EG-VEGF and its receptor PKR1 might play a role in the pathogenesis of adrenocortical tumors and could serve as prognostic markers for this rare malignant disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12672-015-0236-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4630243
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-46302432015-11-06 Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors Heck, Dorothee Wortmann, Sebastian Kraus, Luitgard Ronchi, Cristina L. Sinnott, Richard O. Fassnacht, Martin Sbiera, Silviu Horm Cancer Original Paper Angiogenesis is essential for tumor growth and metastasis. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an angiogenic factor predominantly expressed in steroidogenic organs like the adrenal gland, ovary, testes, and placenta. EG-VEGF has antiapoptotic, mitogenic, and chemoattractive properties mediated via the two G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). We investigated the expression of EG-VEGF and its receptors in a large number of normal adrenal glands (NAG), adrenocortical adenomas (ACA), and carcinomas (ACC) using real-time PCR (NAG, n = 12; ACA, n = 24; and ACC, n = 30) and immunohistochemistry (NAG, n = 9; ACA, n = 23; and ACC, n = 163) and evaluated its impact on patients’ survival. EG-VEGF, PKR1, and PKR2 mRNA and protein are expressed in NAG and the vast majority of ACA and ACC samples. The mean EG-VEGF mRNA expression was significantly lower in ACC (606.5 ± 77.1 copies) compared to NAG (4,043 ± 1,111) and cortisol-producing adenomas (CPA) (4,433 ± 2,378) (p < 0.01 and p < 0.05, respectively). However, cytoplasmic and nuclear EG-VEGF protein expression was either significantly higher or similar in ACC (H score 2.4 ± 0.05, p < 0.05 and 1.7 ± 0.08, n.s., respectively) compared to NAG (1.8 ± 0.14 and 1.7 ± 0.2). Nuclear protein expression of either EG-VEGF or PKR1 or both is predictive for a higher mortality compared to patients without nuclear expression (hazard ratio (HR) = 5.15; 95 % confidence interval (CI) = 1.24–21.36, n = 100, p = 0.02 independent of age, sex, and tumor stage). These findings suggest that EG-VEGF and its receptor PKR1 might play a role in the pathogenesis of adrenocortical tumors and could serve as prognostic markers for this rare malignant disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12672-015-0236-z) contains supplementary material, which is available to authorized users. Springer US 2015-10-16 /pmc/articles/PMC4630243/ /pubmed/26475302 http://dx.doi.org/10.1007/s12672-015-0236-z Text en © The Author(s) 2015 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Heck, Dorothee
Wortmann, Sebastian
Kraus, Luitgard
Ronchi, Cristina L.
Sinnott, Richard O.
Fassnacht, Martin
Sbiera, Silviu
Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
title Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
title_full Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
title_fullStr Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
title_full_unstemmed Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
title_short Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
title_sort role of endocrine gland-derived vascular endothelial growth factor (eg-vegf) and its receptors in adrenocortical tumors
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630243/
https://www.ncbi.nlm.nih.gov/pubmed/26475302
http://dx.doi.org/10.1007/s12672-015-0236-z
work_keys_str_mv AT heckdorothee roleofendocrineglandderivedvascularendothelialgrowthfactoregvegfanditsreceptorsinadrenocorticaltumors
AT wortmannsebastian roleofendocrineglandderivedvascularendothelialgrowthfactoregvegfanditsreceptorsinadrenocorticaltumors
AT krausluitgard roleofendocrineglandderivedvascularendothelialgrowthfactoregvegfanditsreceptorsinadrenocorticaltumors
AT ronchicristinal roleofendocrineglandderivedvascularendothelialgrowthfactoregvegfanditsreceptorsinadrenocorticaltumors
AT sinnottrichardo roleofendocrineglandderivedvascularendothelialgrowthfactoregvegfanditsreceptorsinadrenocorticaltumors
AT fassnachtmartin roleofendocrineglandderivedvascularendothelialgrowthfactoregvegfanditsreceptorsinadrenocorticaltumors
AT sbierasilviu roleofendocrineglandderivedvascularendothelialgrowthfactoregvegfanditsreceptorsinadrenocorticaltumors